Rejoy Health

Emerging

SF YC W21 AI patient education for thyroid and chronic conditions at $125M valuation Sep 2024; $22.2M from Google, Harvard endowment, Gaingels/YC competing with Paloma Health for AI-driven medical knowledge accessibility for underdiagnosed chronic disease.

Company Overview

About Rejoy Health

Rejoy Health is a San Francisco-based AI-powered healthcare platform — backed by Y Combinator (W21) with $22.2 million in total funding from Y Combinator, Google, Gaingels, and the Harvard University endowment fund, achieving a $125 million valuation in September 2024 — providing patients with chronic conditions (particularly thyroid disorders) with AI-driven medical knowledge accessibility tools and subscription-based treatment and management services that bridge the gap between patient symptoms, lab results, and clinical recommendations. Founded in 2020 by former Facebook and Microsoft engineers and launched through Y Combinator, Rejoy translates complex medical information into personalized, understandable patient guidance using artificial intelligence.

Business Model & Competitive Advantage

Rejoy Health's AI patient education platform addresses the medical knowledge gap that creates health outcome disparities for patients with complex chronic conditions: thyroid disorders (hypothyroidism, hyperthyroidism, Hashimoto's thyroiditis, Graves' disease) affect 20+ million Americans but are chronically underdiagnosed and undertreated because thyroid lab interpretation is nuanced — TSH, free T3, free T4, thyroid antibody levels interact in ways that differ by individual, and the difference between "normal range" and "optimal range" for symptom resolution is clinically meaningful but rarely explained by endocrinologists in 15-minute appointments. Rejoy's AI (processing patient symptoms, lab results, medication history, and lifestyle factors) generates personalized explanations of what the lab values mean for each patient's specific situation — helping patients understand their condition, prepare informed questions for their physicians, and track their progress over time.

Competitive Landscape 2025–2026

In 2025, Rejoy Health competes in the AI patient education, digital health management, and direct-to-patient thyroid care market with Paloma Health (thyroid-focused telemedicine, $60M raised), Parsley Health (functional medicine platform, $60M raised), and Everlywell (at-home testing and digital health, $175M raised) for thyroid patient chronic condition management platform adoption. Harvard University endowment's direct investment (Harvard Management Company manages $54B in endowment assets and occasionally co-invests in early-stage companies) and Google's participation provide both institutional capital and strategic validation. The $125M September 2024 valuation demonstrates investor conviction in the AI health education market for underserved chronic conditions. The 2025 strategy focuses on expanding the chronic condition coverage beyond thyroid disorders (to hormonal conditions, autoimmune disorders, and metabolic health), building the physician partnership channel for clinical integration of Rejoy's patient education platform, and growing the subscription model for ongoing condition management and lab tracking.

Revenue
$125M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Rejoy Health is an emerging player bringing innovative solutions to the Healthcare market.

Growth Stage

Rejoy Health has achieved $125M in revenue, demonstrating strong product-market fit.

Frequently Asked Questions

Not So Random Others

Hermes Robotics

Manufacturing
B2bHardwareManufacturingAi PoweredAutomationStartup

Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma

Duckie

Infrastructure
B2bPlatformAi PoweredAutomation

Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit

Oda Studio

Real Estate & Property Tech
B2bProptechAi PoweredSaas

Oda Studio is a United States-based AI-powered interior design platform — backed by Y Combinator (W20) — providing homebuyers, renters, and design enthusiasts with AI tools to discover their personal

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Bucket Robotics

Manufacturing
B2bHardwareManufacturingAi PoweredAutomationStartup

Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

Compare Rejoy Health with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Rejoy Health

Claim This Profile

Are you from Rejoy Health? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Rejoy Health Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Rejoy Health vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →